BMP2 and hyperphosphatemia: Hyperphosphatemia was identified to convert the contractile phenotype of vascular smooth muscle cells to the osteogenic phenotype, during which DNA 6 mA demethylated by ALKBH1 facilitated OCT4 to recognize and bind to BMP2 promoter (Ouyang et al. 2021).